Online tools & resources

News and Events

demo_pricing_button      login_button

Release News

PharmaPendium 2013.3 Release


The content release includes the following updates:

FDA Approval Packages:


• 15 new drugs:

Ado-Trastuzumab Emtansine
Alogliptin Benzoate
Alogliptin Benzoate; Metformin Hydrochloride
Alogliptin Benzoate; Pioglitazone Hydrochloride
Bedaquiline Fumarate
Crofelemer
Glycerol Phenylbutyrate
Hydrocodone Bitartrate; Chlorpheniramine Maleate
Lomitapide Mesylate
Loxapine
Mipomersen Sodium
Pomalidomide
Raxibacumab
Sodium, Potassium, Magnesium Sulfates; Sodium, Potassium Chlorides; Sodium Bicarbonate
Teduglutide Recombinant


• 1,029 new FDA Approval Documents
• 20,934 new pages of FDA Approval Documents

Extracted PK data observations:


• 10,486 new extracted PK data lines

Extracted Safety data observations:

• 11,022 new extracted safety data lines

Metabolizing Enzymes Database:

• 164,265 new safety records

Published Toxicity Database:

• 367 new safety records

The new totals for PharmaPendium are:
•    1,729,917 pages of FDA Approval documents (Including FDA Classic Collection)
•    76,202 documents of FDA Approval documents (Including FDA Classic Collection)
•    4,145 drugs with data in PharmaPendium
•    1,239,405  extracted safety data lines
•    1,331,058 extracted PK data lines
•    164,265 extracted ME data lines
•    5,259,028 AERS (post-marketing) reports
•    6,002 documents / 107,300 pages of EMA Approval documents
•    11,842 documents / 491,869 pages of FDA Advisory Committee Meeting documents
•    10,906 documents / 308,015 pages of FDA Classic Collection



Year-To-Date EMA and FDA approval documents statistics for 2013
(PP 2013.1 + PP 2013.2 + 2013.3):


•    4,626 new documents
•    90,974 new pages
•    37,692 new extracted PK data observations
•    58,529 new extracted safety data observations
•    164,265 new extracted ME data observations
•    26 new drugs

Newsletter